Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. (2020)

First Author: Van Der Lee SJ

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00401-019-02107-8

PubMed Identifier: 31955222

Publication URI: http://europepmc.org/abstract/MED/31955222

Type: Journal Article/Review

Volume: 139

Parent Publication: Acta neuropathologica

Issue: 5

ISSN: 0001-6322